bioRxiv Science⌕ Search

Biology subjects

Tkachenko, S.

Publications and source records attributed to Tkachenko, S..

2 recordsLinked to original sources

Can public good producing subclones invade a population of non-producers?

Cancer progression is increasingly understood as an evolutionary process shaped not only by competition but also by cooperative interactions including those mediated through diffusible "public goods" (PGs). Classical evolutionary game theory predicts that PG-producing (altruistic) subclones cannot invade well-mixed populations of non-producers, creating a paradox given their observed emergence in tumors. Here, we resolve this contradiction by combining stochastic spatial simulations with an analytically tractable Moran model to study the invasion dynamics of PG-producing cells in structured populations. Starting from a single producer cell, we explicitly model stochastic PG secretion, diffusion, binding/unbinding, and cell proliferation across biologically relevant parameter ranges. We demonstrate that spatial structure fundamentally alters invasion dynamics, enabling PG producers to invade and establish even when production incurs a fitness cost. Both numerical and analytical approaches converge on a key unifying parameter, a characteristic length scale{delta} , that captures the combined effects of diffusivity, binding kinetics, and degradation. This length scale determines the spatial extent of PG availability and thus the selective advantage of producers. We identify distinct regimes: when PGs are localized (small{delta} ), producers preferentially benefit and invasion is likely; when PGs are widely dispersed (large{delta} ), benefits are shared and invasion approaches neutrality or is suppressed by costs. Our results highlight that invasion of cooperative traits is governed by spatially mediated resource localization rather than intrinsic fitness alone. This framework provides a mechanistic basis for understanding the emergence of cooperative subclones in tumors and suggests that modulating biophysical transport properties of signaling molecules could influence tumor evolution, metastasis, and therapeutic resistance.

evolutionary biology↗

Platinum chemotherapy induces lymphangiogenesis to prime tissues for tumor metastasis

Chemotherapy has been used to inhibit cancer growth for decades, but emerging evidence shows it can affect the tumor stroma unintentionally promoting cancer malignancy. After treatment of primary tumors, remaining drugs drain via lymphatics. Though all drugs interact with the lymphatics, we know little of their impact on them. Here, we show a previously unknown effect of platinums, a widely used class of chemotherapeutics, to directly induce systemic lymphangiogenesis and activation. These changes are dose-dependent, long-lasting, and occur in healthy and cancerous tissue in multiple mouse models of breast cancer. We saw similar effects in human ovarian and breast cancer patients whose treatment regimens included platinums. Carboplatin treatment of healthy mice prior to mammary tumor inoculation increases cancer metastasis as compared to no pre-treatment. These platinum-induced phenomena could be blocked by VEGFR3 inhibition. These findings have implications for cancer patients receiving platinums and may support the inclusion of anti-VEGFR3 therapy into treatment regimens or differential design of treatment regimens to alter these potential effects. SummaryPlatinum chemotherapy induces VEGFR3-dependent lymphangiogenesis, priming tissues for metastasis of breast cancer. Inhibition of VEGFR3 via antibody blockade can reverse these effects.

cancer biology↗